Penicillin G acylase market was valued at US$ 151.3 million in 2024 and is projected to hit the market valuation of US$ 251.4 million by 2033 at a CAGR of 5.8% during the forecast period 2025–2033.
Intravenous hydration therapy market was valued at US$ 2.8 billion in 2024 and is projected to hit the market valuation of US$ 4.9 billion by 2033 at a CAGR of 6.2% during the forecast period 2025–2033.
US cell culture supplements market was valued at US$ 835.9 million in 2024 and is projected to hit the market valuation of US$ 2,491.6 million by 2033 at a CAGR of 12.9% during the forecast period 2025–2033.
Veterinary regenerative medicine market was valued at US$ 345.4 million in 2024 and is projected to hit the market valuation of US$ 1,045.9 million by 2033 at a CAGR of 13.1% during the forecast period 2025–2033.
Central nervous system therapeutic market was valued at US$ 129.38 billion in 2024 and is projected to hit the market valuation of US$ 235.87 billion by 2033 at a CAGR of 6.90% during the forecast period 2025–2033.
Saliva collection and diagnostics market was valued at US$ 826.6 million in 2024 and is projected to hit the market valuation of US$ 1,260.5 million by 2033 at a CAGR of 4.8% during the forecast period 2025–2033.
Viral vectors & plasmid DNA manufacturing market was valued at US$ 4.21 billion in 2024 and is projected to hit the market valuation of US$ 20.30 billion by 2033 at a CAGR of 19.1% during the forecast period 2025–2033.